MBI vs Lotus Pharm: monthly revenue

Monthly revenue and year-on-year change for MBI (1783) and Lotus Pharm (1795) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ MBI ━ Lotus Pharm

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthMBIYoYLotus PharmYoY
Oct 2026NT$74.4 million+17.3%NT$2.13 billion-22.5%
Sep 2026NT$88.1 million+35.3%NT$2.77 billion+128.0%
Aug 2026NT$68.5 million-2.5%NT$2.11 billion+81.7%
Jul 2026NT$63.8 million-2.6%NT$2.49 billion+3.9%
Jun 2026NT$86.1 million+9.2%NT$3.4 billion+225.5%
May 2026NT$73.6 million-4.4%NT$2.32 billion+105.8%
Apr 2026NT$61.3 million+15.8%NT$3.09 billion+19.9%
Mar 2026NT$69.9 million+0.1%NT$4.35 billion+173.6%
Feb 2026NT$48 million+20.9%NT$2.24 billion+131.5%
Jan 2026NT$73 million+7.9%NT$2.05 billion-5.5%
Dec 2025NT$92.9 million+33.1%NT$2.44 billion+66.9%
Nov 2025NT$68.4 million-7.4%NT$1.06 billion-0.2%
Oct 2025NT$63.4 million+2.3%NT$2.75 billion+46.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16